These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 11363839)
41. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection. Wilkins E J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268 [No Abstract] [Full Text] [Related]
42. New treatment options. Fornataro K; Jefferys R Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013 [TBL] [Abstract][Full Text] [Related]
52. Standard treatments for HIV, Spring 1997. Smith D AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255 [TBL] [Abstract][Full Text] [Related]
53. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
54. Update from the 5th Conference on Retroviruses and Opportunistic Infections. Vazquez E Posit Aware; 1998; 9(3):21-3. PubMed ID: 11365483 [TBL] [Abstract][Full Text] [Related]
55. Fortovase approved: new saquinavir formulation. James JS AIDS Treat News; 1997 Nov; (No 283):1. PubMed ID: 11364907 [TBL] [Abstract][Full Text] [Related]
56. The new antiretroviral arsenal. Smith D AIDS Treat News; 1996 Nov; (No 259):4-5. PubMed ID: 11364001 [TBL] [Abstract][Full Text] [Related]